Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
PharmAkea Therapeutics logo — Pioneering high-quality small molecule drug candidates for f...

PharmAkea Therapeutics

Pioneering high-quality small molecule drug candidates for fibroproliferative diseases.

Founded 2012 Series A Total: $10.00M Biotechnology, Health and Wellness +1

General Information

Company Name PharmAkea Therapeutics
Founded Year 2012
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with PharmAkea Therapeutics. To contact PharmAkea Therapeutics, visit pharmakea.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PharmAkea Therapeutics compare?

A PDF of PharmAkea Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PharmAkea Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About PharmAkea Therapeutics

PharmAkea Therapeutics, founded in 2012, is a biopharmaceutical company based in San Diego, CA. The company's focus is on pioneering high-quality, small molecule drug candidates for fibroproliferative diseases. Its slogan, "Pioneering high-quality small molecule drug candidates for fibroproliferative diseases," encapsulates its mission. The latest investment for PharmAkea was a $10.00M Series A investment on 07 October 2013, led by Bay City Capital. The company operates in the Biotechnology, Health and Wellness, and Pharmaceutical industries. PharmAkea's research and development efforts are directed towards addressing protein targets associated with fibroproliferative diseases, a significant area within the healthcare and biotechnology sectors. With a solid investment backing, the company is well-positioned to continue its innovative work in developing treatments for these challenging conditions.

Business keywords: biopharmaceutical, San Diego, drug candidates, fibroproliferative diseases, small molecule, protein targets

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $10.00M 1
Bay City Capital
Bay City Capital
07 Oct 2013

PharmAkea Therapeutics Alternatives & Competitors

View All Alternatives
PharmAkea Therapeutics vs
Cullgen Inc.
Cullgen Inc. United States

Powering protein degradation for tomorrow's medicines

Acquired
27 employees
Biotechnology, Pharmaceutical
PharmAkea Therapeutics vs
Expansion Therapeutics
Expansion Therapeutics United States

Bringing transformative therapies to patients with severe RNA-mediated diseases.

Venture round
29 employees
Biotechnology, Health Care
PharmAkea Therapeutics vs
VentiRx Pharmaceuticals
VentiRx Pharmaceuticals

Advancing healthcare innovations with targeted therapies for cancer, respiratory, and autoimmune dis...

Series B
Biotechnology, Health Care
View all alternatives

FAQ About PharmAkea Therapeutics

Pioneering high-quality small molecule drug candidates for fibroproliferative diseases.
PharmAkea Therapeutics was founded in 2012.
PharmAkea Therapeutics operates in Biotechnology, Health and Wellness and Pharmaceutical. Its work centres on biopharmaceutical, San Diego, drug candidates and fibroproliferative diseases.
PharmAkea Therapeutics has completed 1 funding round, raising a total of $10.00M. The latest funding stage is Series A.
Top alternatives and competitors to PharmAkea Therapeutics include Cullgen Inc., Expansion Therapeutics, VentiRx Pharmaceuticals, ALSP, Inc., 858 Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PharmAkea Therapeutics and Cullgen Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PharmAkea Therapeutics, https://bouncewatch.com/company/pharmakea-therapeutics, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout